195
Views
54
CrossRef citations to date
0
Altmetric
Review

Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine

Pages 3955-3971 | Published online: 12 Jun 2015

References

  • EnhsenAKramerWWessGBile acids in drug discoveryDrug Discov Today199839409418
  • Maldonado-ValderramaJWildePMacierzankaAMackieAThe role of bile salts in digestionAdv Colloid Interface Sci20111651364621236400
  • LiGIntestinal probiotics: interactions with bile salts and reduction of cholesterolProcedia Environ Sci201212Part B11801186
  • ConacherMAlexanderJBrewerJMOral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)Vaccine20011920–222965297411282208
  • FuZDKlaassenCDIncreased bile acids in enterohepatic circulation by short-term calorie restriction in male miceToxicol Appl Pharmacol2013273368069024183703
  • PolsTWHNoriegaLGNomuraMAuwerxJSchoonjansKThe bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammationJ Hepatol20115461263127221145931
  • MadenciDEgelhaafSUSelf-assembly in aqueous bile salt solutionsCurr Opin Colloid Interface Sci2010151–2109115
  • BaptissartMVegaAMaqdasySBile acids: from digestion to cancersBiochimie201395350451722766017
  • DegirolamoCModicaSPalascianoGMoschettaABile acids and colon cancer: solving the puzzle with nuclear receptorsTrends Mol Med2011171056457221724466
  • MorimotoKUeharaYIwanagaKInfluence of absorption enhancers (bile salts) and the preservative (benzalkonium chloride) on mucociliary function and permeation barrier function in rabbit tracheasEur J Pharm Sci1998632252309795068
  • AtanackovicMPosaMHeinleHGojković-BukaricaLCvejićJSolubilization of resveratrol in micellar solutions of different bile acidsColloids Surf B Biointerfaces200972114815419411167
  • MaestrelliFCirriMMenniniNZerroukNMuraPImprovement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile componentsEur J Pharm Biopharm201178338539321439375
  • SelvamSAndrewsMEMishraAKA photophysical study on the role of bile salt hydrophobicity in solubilizing amphotericin B aggregatesJ Pharm Sci200998114153416019283765
  • ElnaggarYSEl-RefaieWMEl-MassikMAAbdallahOYLecithin-based nanostructured gels for skin delivery: an update on state of art and recent applicationsJ Control Release2014180102424531009
  • RomeoVDdeMeirelesJCGriesWJOptimization of systemic nasal drug delivery with pharmaceutical excipientsAdv Drug Deliv Rev1998291–211713310837583
  • ShinS-CKimJ-YEnhanced permeation of triamcinolone acetonide through the buccal mucosaEur J Pharm Biopharm200050221722010962230
  • ShinS-CChoC-WYangK-HDevelopment of lidocaine gels for enhanced local anesthetic actionInt J Pharm20042871–2737815541914
  • BhatSMaitraULow molecular mass cationic gelators derived from deoxycholic acid: remarkable gelation of aqueous solventsTetrahedron2007633173097320
  • El-RefaiebWMElnaggerYSEl-MassikbMAAbdallahaOYNovel self-assembled, gel-core hyaluosomes for non-invasive management of osteoarthritis: in-vitro optimization, ex-vivo and in-vivo permeationPharm Res Epub3172015
  • ElnaggarYSEl-MassikMAAbdallahOYFabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticlesInt J Nanomedicine201163195320522238508
  • ElnaggarYSEl-MassikMAAbdallahOYSelf-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimizationInt J Pharm20093801–213314119635537
  • ElsheikhMAElnaggarYSGoharEYAbdallahOYNanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisalInt J Nanomedicine201273787380222888234
  • FreagMSElnaggarYSAbdallahOYLyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeationInt J Nanomedicine201382385239723861584
  • FreagMSElnaggarYSAbdallahOYDevelopment of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeationInt J Pharm2013454146247123830765
  • ElnaggarYSEl-MassikMAAbdallahOYSildenafil citrate nanoemulsion vs self-nanoemulsifying delivery systems: rational development and transdermal permeationInt J Nanotechnol201188749763
  • HardeHSiddhapuraKAgrawalAKJainSDevelopment of dual toxoid-loaded layersomes for complete immunostimulatory response following peroral administrationNanomedicine (Lond)20151071077109125929566
  • YingsukwattanaKPuttipipatkhachornSRuktanonchaiUSarisutaNEnhanced permeability across Caco-2 cell monolayers by specific mannosylating ligand of buserelin acetate proliposomesJ Liposome Res Epub2015611125945393
  • ParmentierJBeckerMMHeintzUFrickerGStability of liposomes containing bio-enhancers and tetraether lipids in simulated gastrointestinal fluidsInt J Pharm20114051–221021721145956
  • JainSHardeHIndulkarAAgrawalAKImproved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administrationNanomedicine201410243144024036099
  • GadrasCSantaellaCVierlingPImproved stability of highly fluorinated phospholipid-based vesicles in the presence of bile saltsJ Control Release199957129349863036
  • HuSNiuMHuFIntegrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal mediaInt J Pharm20134411–269370023089580
  • AndrieuxKForteLLesieurSPaternostreMOllivonMGrabielle-MadelmontCSolubilisation of dipalmitoylphosphatidylcholine bilayers by sodium taurocholate: a model to study the stability of liposomes in the gastrointestinal tract and their mechanism of interaction with a model bile saltEur J Pharm Biopharm200971234635518835441
  • MartinCThongborisuteJTakeuchiHYamamotoHKawashimaYAlparHOCholesterol–bile salt vesicles as potential delivery vehicles for drug and vaccine deliveryInt J Pharm2005298233934315967607
  • PremanandBPrabakaranMKienerTKKwangJRecombinant baculovirus associated with bilosomes as an oral vaccine candidate against HEV71 infection in micePLoS One201382e5553623390538
  • SeniorKBilosomes: the answer to oral vaccine delivery?Drug Discov Today20016201031103211590024
  • ShuklaAKatareOPSinghBVyasSPM-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomesInt J Pharm20103851–2475219835938
  • ShuklaAKhatriKGuptaPNGoyalAKMehtaAVyasSPOral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes)J Pharm Pharm Sci2008111596618445364
  • ShuklaASinghBKatareOPSignificant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomesBr J Pharmacol20111642b82082721506959
  • SinghPPrabakaranDJainSMishraVJaganathanKSVyasSPCholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunizationInt J Pharm2004278237939015196642
  • NiuMTanYGuanPEnhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic studyInt J Pharm20144601–211913024275447
  • ChenYLuYChenJEnhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile saltInt J Pharm20093761–215316019394416
  • KhatunZNurunnabiMChoKJLeeYKImaging of the GI tract by QDs loaded heparin-deoxycholic acid (DOCA) nanoparticlesCarbohydr Polym20129041461146822944403
  • GaoFLiLZhangHDeoxycholic acid modified-carboxymethyl curdlan conjugate as a novel carrier of epirubicin: in vitro and in vivo studiesInt J Pharm20103921–225426020347028
  • HolmRMullertzAMuHBile salts and their importance for drug absorptionInt J Pharm20134531445523598075
  • Torcello-GómezAMaldonado-ValderramaJDe VicenteJCabrerizo-VílchezMAGálvez-RuizMJMartín-RodríguezAInvestigating the effect of surfactants on lipase interfacial behaviour in the presence of bile saltsFood Hydrocolloids2011254809816
  • ArayaHNagaoSTomitaMHayashiMThe novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion I: enhancing effects on oral bioavailability of poorly water soluble compounds in rats and beagle dogsDrug Metab Pharmacokinet200520424425616141604
  • MiyakeKArimaHIrieTHirayamaFUekamaKEnhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated ratsBiol Pharm Bull199922166729989664
  • van HasseltPMJanssensGESlotTKThe influence of bile acids on the oral bioavailability of vitamin K encapsulated in polymeric micellesJ Control Release2009133216116818955093
  • KimEJHanKSLeeMGEnhanced absorption of oral furosemide by bile juice in ratsRes Commun Mol Pathol Pharmacol1999104110711010604283
  • ZhangZGaoFJiangSBile salts enhance the intestinal absorption of lipophilic drug loaded lipid nanocarriers: mechanism and effect in ratsInt J Pharm20134521–237438123694804
  • LofmanMKoivukorpiJNoponenVSaloHSievänenEBile acid alkylamide derivatives as low molecular weight organogelators: systematic gelation studies and qualitative structural analysis of the systemsJ Colloid Interface Sci2011360263364421621792
  • PatraDAhmadiehDAridiRStudy on interaction of bile salts with curcumin and curcumin embedded in dipalmitoyl-sn-glycero-3-phosphocholine liposomeColloids Surf B Biointerfaces201311029630423732808
  • RuppCSteckelHMullerBWMixed micelle formation with phosphatidylcholines: the influence of surfactants with different molecule structuresInt J Pharm20103871–212012820005930
  • GautrotJEZhuXXBiodegradable polymers based on bile acids and potential biomedical applicationsJ Biomater Sci2006171011231139
  • YangJGaoCLüSZhangXYuCLiuMPhysicochemical characterization of amphiphilic nanoparticles based on the novel starch-deoxycholic acid conjugates and self-aggregatesCarbohydr Polym201410283884524507354
  • TangXCaiSZhangRPaclitaxel-loaded nanoparticles of star-shaped cholic acid-core PLA-TPGS copolymer for breast cancer treatmentNanoscale Res Lett20138142024134303
  • ZengXTaoWMeiLHuangLTanCFengSSCholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancerBiomaterials201334256058606723694904
  • LiYXiaoKLuoJLeeJPanSLamKSA novel size-tunable nanocarrier system for targeted anticancer drug deliveryJ Control Release2010144331432320211210
  • GaoF-PZhangHZLiuLRPreparation and physicochemical characteristics of self-assembled nanoparticles of deoxycholic acid modified-carboxymethyl curdlan conjugatesCarbohydr Polym2008714606613
  • HeCHuYYinLTangCYinCEffects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticlesBiomaterials201031133657366620138662
  • XiaoKLuoJFowlerWLA self-assembling nanoparticle for paclitaxel delivery in ovarian cancerBiomaterials200930306006601619660809
  • LuoJXiaoKLiYWell-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatmentBioconjug Chem20102171216122420536174
  • DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
  • ZahrASDavisCAPishkoMVMacrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol)Langmuir200622198178818516952259
  • XiaoKLiYLuoJThe effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticlesBiomaterials201132133435344621295849
  • MaNMaCLiCInfluence of nanoparticle shape, size, and surface functionalization on cellular uptakeJ Nanosci Nanotechnol201313106485649824245105
  • LesniakASalvatiASantos-MartinezMJRadomskiMWDawsonKAÅbergCNanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiencyJ Am Chem Soc201313541438144423301582
  • TruongNPWhittakerMRMakCWDavisTPThe importance of nanoparticle shape in cancer drug deliveryExpert Opin Drug Deliv201512112914225138827
  • MahajanSMahajanRKInteractions of phenothiazine drugs with bile salts: micellization and binding studiesJ Colloid Interface Sci2012387119420422939256
  • TanYQiJLuYHuFYinZWuWLecithin in mixed micelles attenuates the cytotoxicity of bile salts in Caco-2 cellsToxicol In Vitro201327271472023220290
  • IsraelachviliJNMitchellDJNinhamBWTheory of self-assembly of lipid bilayers and vesiclesBiochim Biophys Acta19774702185201911827
  • YuJNZhuYWangLEnhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micellesActa Pharmacol Sin201031675976420523347
  • WackerMSchubertRFrom mixed micelles to liposomes: critical steps during detergent removal by membrane dialysisInt J Pharm19981621–2171175
  • NiuMLuYHovgaardLHypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered doseEur J Pharm Biopharm201281226527222369880
  • JainSIndulkarAHardeHAgrawalAKOral mucosal immunization using glucomannosylated bilosomesJ Biomed Nanotechnol201410693294724749389
  • AburahmaMHBile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccinesDrug Deliv2014121
  • YangLTuckerIGOstergaardJEffects of bile salts on propranolol distribution into liposomes studied by capillary electrophoresisJ Pharm Biomed Anal201156355355921784594
  • GuanPLuYQiJEnhanced oral bioavailability of cyclosporine A by liposomes containing a bile saltInt J Nanomedicine2011696597421720508
  • ElsheikhMAElnaggarYSAbdallahOYRationale employment of cell culture versus conventional techniques in pharmaceutical appraisal of nanocarriersJ Control Release20141949210225194779
  • HeinenCAReussSAmidonGLLangguthPIon pairing with bile salts modulates intestinal permeability and contributes to food-drug interaction of BCS class III compound trospium chlorideMol Pharm201310113989399623750707
  • SongK-HChungS-JShimC-KEnhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile saltsJ Control Release2005106329830815979756
  • KokkonaMKallinteriPFatourosDAntimisiarisSGStability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid compositionEur J Pharm Sci20009324525210594380
  • KiselevMAJanichMHildebrandAStrunzPNeubertRHHLombardoDStructural transition in aqueous lipid/bile salt [DPPC/NaDC] supramolecular aggregates: SANS and DLS studyChem Phys20134249399
  • NiuMLuYHovgaardLWuWLiposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradationInt J Nanomedicine201161155116621822379
  • MontanariJVeraMMensiEMorillaMRomeroENanoberries for topical delivery of antioxidantsJ Cosmet Sci201364646948124397884
  • PaolinoDCoscoDCilurzoFImproved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesiclesJ Control Release2012162114315122698941
  • El MaghrabyGMWilliamsACBarryBWOestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentrationInt J Pharm20001961637410675708
  • DaiYZhouRLiuLLuYQiJWuWLiposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeationInt J Nanomedicine201381921193323690687
  • FuQFuHLHuanLPreparation of cefquinome sulfate proliposome and its pharmacokinetics in rabbitIran J Pharm Res201312461162124523741
  • VelpulaAJukantiRJangaKYProliposome powders for enhanced intestinal absorption and bioavailability of raloxifene hydrochloride: effect of surface chargeDrug Dev Ind Pharm201339121895190622458264
  • ArturssonPKarlssonJCorrelation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochem Biophys Res Commun199117538808851673839
  • CunaMAlonso-SandelMRemuñán-LópezCPivelJPAlonso-LebreroJLAlonsoMJDevelopment of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein deliveryJ Nanosci Nanotechnol200669–102887289517048495
  • JainSVyasSPMannosylated niosomes as adjuvant-carrier system for oral mucosal immunizationJ Liposome Res200616433134517162576
  • OwenRLPierceNFAppleRTCrayWCJrM cell transport of Vibrio cholerae from the intestinal lumen into Peyer’s patches: a mechanism for antigen sampling and for microbial transepithelial migrationJ Infect Dis19861536110811182422297
  • BarnwellSGLaudanskiTDwyerMReduced bioavailability of atenolol in man: the role of bile acidsInt J Pharm1993893245250
  • SasakiMMaedaASakamotoKFujimuraAEffect of bile acids on absorption of nitrendipine in healthy subjectsBr J Clin Pharmacol200152669970111736882
  • AmenitschHEdlundHKhanAMarquesEFLa MesaCBile salts form lyotropic liquid crystalsColloids Surfaces A Physicochem Eng Aspects200321317992
  • PaliwalRPaliwalSRMishraNMehtaAVyasSPEngineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexateInt J Pharm20093801–218118819576973
  • WilkhuJSMcNeilSEAndersonDEPerrieYCharacterization and optimization of bilosomes for oral vaccine deliveryJ Drug Target2013213291299
  • BashaMAbd El-AlimSHShammaRNAwadGEDesign and optimization of surfactant-based nanovesicles for ocular delivery of ClotrimazoleJ Liposome Res201323320321023607316